Alison Handley

Statistics

Publications

Citations

293

H-Index

Active since

2011

Affiliations

Takeda (United States)(Current)

Deerfield (United States)

SUNY Downstate Health Sciences University

University of Connecticut

Virginia Commonwealth University

Alison Handley is an author at Takeda (United States) specializing in antihypertensive drug therapy, hypertension pharmacotherapy, and cardiovascular pharmacotherapy.

Publications per year

2011–2017

Publications

Comparison of the Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil vs Valsartan by Ambulatory Blood Pressure Monitoring

Domenic Sica, William B. White, Michael A. Weber et al. · Journal of Clinical Hypertension · 2011 · 118 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Antihypertensive Efficacy of Hydrochlorothiazide vs Chlorthalidone Combined with Azilsartan Medoxomil

George L. Bakris, Domenic Sica, William B. White et al. · The American Journal of Medicine · 2012 · 87 citations

Pharmacy, Pharmacology, Pharmacotherapy +10

Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril

Gerd Bönner, George L. Bakris, Domenic Sica et al. · Journal of Human Hypertension · 2013 · 60 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Comparison of long‐term safety of fixed‐dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide

Joel M. Neutel, William C. Cushman, Eric Lloyd et al. · Journal of Clinical Hypertension · 2017 · 18 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label study

Alison Handley, Eric Lloyd, Andrew W. Roberts et al. · Clinical and Experimental Hypertension · 2016 · 10 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–5 of 5